Company Overview and News
Eastman Chemical Company (EMN - Free Report) is raising the prices of Glycol Ethers and Glycol Ethers Esters effective Aug 24 or as contracts permit. The company is raising off-list prices of two products, PM Acetate and PM Solvent by 5 cents per lb each in North America. Eastman Chemical is taking appropriate pricing actions in response to the rising raw material costs. Eastman Chemical, which is among the prominent chemical companies along with Celanese Corporation (CE - Free Report) , Air Products and Chemicals, Inc.
PPG EMN CE
Methanex Corporation (MEOH - Free Report) has signed natural gas supply agreements with Total Austral SA, Wintershall Energia SA, Pan American Sur SA and Compania General de Combustibles SA for its Chile operations through Jun 1, 2020. These agreements are subject to gas availability in Argentina as well as export permits for gas suppliers from the Argentine Government.
HUN CE MEOH
We are optimistic about The Mosaic Company’s (MOS - Free Report) prospects and believe that the time is right for you to buy the stock as it holds promise and is will sustain the momentum. Let’s delve into the factors that make this fertilizer company an attractive choice. What Makes MOS an Attractive Pick Solid Rank & VGM Score: Mosaic currently has a Zacks Rank #2 (Buy) and a VGM Score of A. Our research shows that stocks with a VGM Score of A or B combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors.
HUN MOS NGVT NGVT.WI CE
Cosan Limited’s (CZZ - Free Report) adjusted net income totaled R$114 million ($31.5 million) in second-quarter 2018, surging 104% from the year-ago tally of R$55.8 million ($17.8 million). However, the net income plunged 26% from R$154 million ($47.4 million) recorded in the previous quarter. Revenues Increase Y/Y In the reported quarter, Cosan’s net revenues came in at R$4,074.5 million ($1,125.6 million), reflecting year-over-year growth of 21%.
CZZ FOX HUN KMG LMHA LMHB FOXA LM CE
Celanese Corporation (CE - Free Report) will raise list and off-list selling prices of acetyl intermediates products. The price hike will be effective immediately or as contracts permit. The company will raise the prices of Acetic Acid by ¥300/MT in China and $55/MT in Asia Outside china (AOC). Prices of Acetic Anhydride will be hiked by ¥400/MT in China and $65/MT in AOC. In AOC, prices of both Butyl Acetate and Ethyl Acetate will increase by $65/MT.
HUN ZEUS CE
Air Products and Chemicals Inc. (APD - Free Report) , Saudi Aramco and ACWA Power have joined forces to form a more than $8-billion Gasification/Power joint venture (JV) at Jazan Economic City (JEC), Saudi Arabia. The gasification assets, power block and the associated utilities will be purchased by the JV from Saudi Aramco. The assets, which are presently under construction, will be transferred to the JV once it successfully commences operations per schedule in 2019.
KMG NGVT NGVT.WI CE
Ingevity Corporation (NGVT - Free Report) has been performing well of late. The chemical maker, currently sporting a Zacks Rank #1 (Strong Buy), has seen its shares pop roughly 26% over the past three months. If you haven’t taken advantage of the share price appreciation yet, the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. What Makes NGVT an Attractive Pick? An Outperformer: Ingevity has outperformed the industry it belongs to over the past year.
HUN KMG NGVT NGVT.WI CE
Huntsman Corporation’s (HUN - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Let’s delve deeper into the factors that make this chemical maker an attractive investment option. What's Working in Favor of HUN? Solid Zacks Rank & Score: Huntsman currently sports a Zacks Rank #1 (Strong Buy) and also has a VGM Score of A.
GJV HUN NWS NWSA KMG NGVT NGVT.WI CE
Koppers Holdings Inc. (KOP - Free Report) logged a profit of $0.6 million or 3 cents per share for second-quarter 2018, down roughly 97% from $19.7 million or 90 cents a year ago. Barring one-time items, earnings were 93 cents per share for the quarter, missing the Zacks Consensus Estimate of $1.10. Koppers, a global provider of wood treatment chemicals, treated wood products and carbon compounds, recorded revenues of $436 million for the quarter, up around 15% year over year.
GD KMG NGVT NGVT.WI CE
Valmont Industries, Inc. (VMI - Free Report) recently announced the acquisition of the operational assets of India-based leading manufacturing facility, Derit Infrastructure Pvt. Ltd. The state-of-the-art facility has manufacturing capabilities for steel lattice structures for power generation, wireless communication, power transmission facilities. It also provides zinc galvanizing services. The deal was funded with cash while the others financial terms have been kept under wraps.
VMI HUN UCTI CE UCTT
The Andersons, Inc. (ANDE - Free Report) posted earnings of 76 cents per share in second-quarter 2018, up 41% from the adjusted earnings of 54 cents reported in the year-ago quarter. Earnings beat the Zacks Consensus Estimate of 8 cents handily. Including one-time items, the company reported a loss of 94 cents in the prior-year quarter. The company did not have any adjustment in this quarter. Operational Update Revenues in the reported quarter dipped around 8% year over year to $911 million.
HUN ANDE KMG UCTI CE UCTT
Albemarle Corporation (ALB - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $90.92 –$96.97 in the past one-month time frame.
ALB HCCDZ HCHC GWRS UCTI SND RLH CE UCTT
American Vanguard Corporation (AVD - Free Report) logged a profit of $5.6 million or 19 cents per share for second-quarter 2018, up around 30% from roughly $4.3 million or 15 cents it earned a year ago. Earnings per share beat the Zacks Consensus Estimate of 17 cents. Revenues surged around 37% year over year to $107 million in the reported quarter, driven by the addition of new product lines from acquisitions completed last year.
KMG NGVT UCTI AVD NGVT.WI CE UCTT
Innospec Inc. (IOSP - Free Report) delivered a profit of $21.8 million or 89 cents per share in second-quarter 2018, down from $26.1 million or $1.06 in the year-ago quarter. Barring one-time items, earnings were $1.00, which missed the Zacks Consensus Estimate of $1.11. The chemical maker’s revenues increased 10% year over year to $358.1 million in the quarter. The top line was driven by sales gains in core business segments.
ELY ICFI KMG IOSP CE
Versum Materials, Inc. (VSM - Free Report) recorded net income of $63.3 million or 58 cents per share in third-quarter fiscal 2018 (ended Jun 30, 2018), up from $52.7 million or 48 cents a year ago. Barring one-time items, adjusted earnings came in at 63 cents per share, which beat the Zacks Consensus Estimate of 61 cents. Sales rose around 20.3% year over year to $350 million, mainly driven by double-digit volume growth in its Advanced Materials product lines and strong volume gains in the Delivery Systems & Services (DS&S) segment.
ELY STLD BLT VSM.WI ICFI BHPBF BHP BBL BHP VSM BHPLF CE
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET